Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Fairley Ricki Louise | 0001971350 | Mar-27-2023 | director |
SHERMAN JEFFREY W | 0001230482 | Oct-05-2021 | director |
PERSKY MARLA | 0001270354 | Oct-05-2021 | director |
JOHNSON JOHN | 0001410781 | Oct-05-2021 | director |
Kong Garheng | 0001435183 | Oct-05-2021 | director |
Schmid John P. | 0001478916 | Oct-05-2021 | director |
Edick Paul R | 0001531178 | Oct-05-2021 | director, officer: See Remarks |
Shannon John Patrick Jr | 0001553595 | Oct-05-2021 | officer: See Remarks |
BORMANN-KENNEDY BARBARA-JEAN ANNE | 0001635065 | Oct-05-2021 | director |
Hecht Beth | 0001652410 | Oct-05-2021 | officer: See Remarks |
HALKUFF DAWN | 0001743658 | Oct-05-2021 | director |
JOHNSON KENNETH ERLAND | 0001743774 | Oct-05-2021 | officer: See Remarks |
PRESTRELSKI STEVEN | 0001744027 | Oct-05-2021 | officer: Chief Scientific Officer |
Pieper Steven | 0001875714 | Oct-05-2021 | officer: Chief Financial Officer |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Xeris Biopharma Holdings, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001867096-24-000032 (33 Act) Size: 95 KB |
Mar-06-2024 | 24726132 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001867096-24-000031 (34 Act) Size: 11882 KB |
Mar-06-2024 | 24725940 |
8-K | Document | Current report filing Acc-no: 0001867096-24-000024 (34 Act) Size: 324 KB |
Mar-06-2024 | 24724374 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-022337 (34 Act) Size: 12 KB |
Feb-13-2024 | 24630011 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000935836-24-000144 (34 Act) Size: 59 KB |
Feb-13-2024 | 24626676 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-24-000018 ( Act) Size: 4 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-24-000017 ( Act) Size: 4 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-24-000016 ( Act) Size: 5 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-24-000015 ( Act) Size: 5 KB |
Jan-31-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-24-000014 ( Act) Size: 8 KB |
Jan-31-2024 | |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001086364-24-004604 (34 Act) Size: 13 KB |
Jan-26-2024 | 24568191 |
8-K | Document | Current report filing Acc-no: 0001867096-24-000003 (34 Act) Size: 220 KB |
Jan-04-2024 | 24509747 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-23-000154 ( Act) Size: 5 KB |
Nov-29-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-23-000151 ( Act) Size: 5 KB |
Nov-21-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-23-000149 ( Act) Size: 4 KB |
Nov-21-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-23-000147 ( Act) Size: 5 KB |
Nov-17-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-23-000145 ( Act) Size: 4 KB |
Nov-17-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001867096-23-000143 ( Act) Size: 5 KB |
Nov-15-2023 | |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001867096-23-000139 (34 Act) Size: 8887 KB |
Nov-09-2023 | 231392464 |
8-K | Document | Current report filing Acc-no: 0001867096-23-000136 (34 Act) Size: 328 KB |
Nov-09-2023 | 231390051 |
Recent 20 filings. View all Xeris Biopharma Holdings, Inc. filings
Huge help thank you for your help .. y'all make it so much easier
Thanks I look forward to using the product to improve my skin tone
It's being easier working on the website. And I recommend, it's a great website
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by